
Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data
29/1/2026
0:00
29:08
Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases?
Credit available for this activity expires: 1/26/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu
Otros episodios de "Keeping Current CME"



No te pierdas ningún episodio de “Keeping Current CME”. Síguelo en la aplicación gratuita de GetPodcast.








